2017
DOI: 10.1055/s-0036-1598000
|View full text |Cite
|
Sign up to set email alerts
|

Fibrinolysis: Biochemistry, Clinical Aspects, and Therapeutic Potential

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(2 citation statements)
references
References 10 publications
0
2
0
Order By: Relevance
“…This activation is driven by tissue Plasminogen Activator (tPA) or urokinase Plasminogen Activator (uPA), the former being released by endothelial cells (specifically, the damaged endothelium of a blood vessel). Both tPA and uPA are regulated by the presence of plasminogen activator inhibitors PAI-I and PAI-2, maintaining the balance that is critical to the hemostatic system [14].…”
Section: Hemostasis and The Hemostatic Systemmentioning
confidence: 99%
“…This activation is driven by tissue Plasminogen Activator (tPA) or urokinase Plasminogen Activator (uPA), the former being released by endothelial cells (specifically, the damaged endothelium of a blood vessel). Both tPA and uPA are regulated by the presence of plasminogen activator inhibitors PAI-I and PAI-2, maintaining the balance that is critical to the hemostatic system [14].…”
Section: Hemostasis and The Hemostatic Systemmentioning
confidence: 99%
“…Plasmin role is in tissue homeostasis and another role is in acts as modulator of immune response [11]. Cardiovascular diseases (CVDs) is a leading cause of death.…”
Section: Introductionmentioning
confidence: 99%